price
AL
NASDAQ · ALEC
Alector, Inc.
Healthcare · Biotechnology
$2.05
Up+$0.09 (+4.59%)
Updated Aug 18, 2026, 11:51 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 265.24M
- P/E ratio
- -1.75
- Dividend yield
- 0.00%
- 52-week range
- $1.37 – $2.74
- Volume
- 913.81K
- Avg. volume
- 1.15M
Price performance
ALEC price history
1M range · 21 trading sessions · Daily adjusted prices
ALEC closed at $2.05 after 21 trading sessions, up 43.36% for the selected period.
- Last close
- $2.05
- Period change
- +43.36%
- Period low
- $1.43
- Period high
- $2.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 17, 2026 | $1.91 | $2.09 | $1.90 | $2.05 | 913.81K |
| Aug 14, 2026 | $2.04 | $2.07 | $1.945 | $1.96 | 649.02K |
| Aug 13, 2026 | $2.15 | $2.15 | $1.98 | $2.04 | 1.29M |
| Aug 12, 2026 | $2.06 | $2.175 | $2.02 | $2.15 | 786.2K |
| Aug 11, 2026 | $1.68 | $2.129 | $1.65 | $2.09 | 5.54M |
| Aug 10, 2026 | $1.77 | $1.78 | $1.60 | $1.69 | 805.59K |
| Aug 7, 2026 | $1.84 | $2.00 | $1.74 | $1.78 | 1.25M |
| Aug 6, 2026 | $1.49 | $2.035 | $1.482 | $1.83 | 5.7M |
| Aug 5, 2026 | $1.56 | $1.57 | $1.46 | $1.49 | 392.31K |
| Aug 4, 2026 | $1.51 | $1.61 | $1.51 | $1.54 | 407.16K |
| Aug 3, 2026 | $1.51 | $1.54 | $1.455 | $1.51 | 359.92K |
| Jul 31, 2026 | $1.62 | $1.62 | $1.485 | $1.51 | 548.29K |
| Jul 30, 2026 | $1.52 | $1.67 | $1.51 | $1.62 | 453.15K |
| Jul 29, 2026 | $1.51 | $1.565 | $1.49 | $1.52 | 307.86K |
| Jul 28, 2026 | $1.51 | $1.54 | $1.475 | $1.52 | 342.8K |
| Jul 27, 2026 | $1.49 | $1.575 | $1.47 | $1.51 | 229K |
| Jul 24, 2026 | $1.50 | $1.5052 | $1.455 | $1.48 | 325.3K |
| Jul 23, 2026 | $1.48 | $1.545 | $1.47 | $1.49 | 607.11K |
| Jul 22, 2026 | $1.53 | $1.535 | $1.49 | $1.53 | 333.44K |
| Jul 21, 2026 | $1.42 | $1.55 | $1.42 | $1.54 | 499.66K |
| Jul 20, 2026 | $1.49 | $1.50 | $1.415 | $1.43 | 463.91K |
Latest ALEC news
The latest Smart Investors Daily articles mentioning ALEC.
Stock researchCompany · Financials
Loading stock research…

